Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Mar;65(3):490-495.
doi: 10.1111/jgs.14668. Epub 2016 Nov 7.

Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis

Smita Nayak  1 , Susan L Greenspan  2
Affiliations
Meta-Analysis

Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis

Smita Nayak et al. J Am Geriatr Soc. 2017 Mar.

Abstract

Objectives: To evaluate the efficacy of treatment options to reduce osteoporotic fracture risk in men.

Design: Systematic review and meta-analysis.

Setting: Randomized clinical trials that evaluated the efficacy of a treatment for osteoporosis or low bone mineral density for adult men and reported fracture outcomes.

Participants: Men.

Measurements: PubMed, Embase, and the Cochrane Library databases were searched for relevant studies. Information was extracted from included studies on participant sociodemographic characteristics, number of male participants, treatment evaluated, comparator for evaluated treatment, study duration, and fracture outcomes. Risk of bias of individual studies was assessed using measures recommended by the Cochrane Collaboration.

Results: Twenty-four articles reporting results for 22 studies (including 4,868 male participants) met strict inclusion criteria. Fixed-effects meta-analyses using the Mantel-Haenszel method demonstrated significantly lower risk of vertebral fractures with alendronate (relative risk (RR) = 0.328, 95% confidence interval (CI) = 0.155-0.692) and risedronate (RR = 0.428, 95% CI = 0.245-0.746) but not with calcitonin (RR = 0.272, 95% CI = 0.046-1.608) or denosumab (RR = 0.256, 95% CI = 0.029-2.238) than in controls. For bisphosphonates as a treatment category, meta-analyses demonstrated significantly lower risk of vertebral fractures (RR = 0.368, 95% CI = 0.252-0.537) and nonvertebral fractures (RR = 0.604, 95% CI = 0.404-0.904) than in controls. The meta-analysis finding that bisphosphonates significantly reduce nonvertebral fracture risk was not robust to sensitivity analysis.

Conclusion: Bisphosphonates reduce the risk of vertebral and possibly nonvertebral fractures for men with osteoporosis. Further studies are needed to evaluate the efficacy of bisphosphonates for reducing nonvertebral fracture risk and the efficacy of nonbisphosphonates for reducing vertebral and nonvertebral fracture risk in men with osteoporosis.

Keywords: fractures; meta-analysis; osteoporosis; systematic review.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: Dr. Greenspan is on the scientific advisory board for Merck & Co. Dr. Nayak has no conflicts of interest.

Figures

Figure 1
Figure 1
Flow diagram of literature search and study selection
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014 Nov;29(11):2520–2526. - PMC - PubMed
    1. U.S. Department of Health and Human Services. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004. Bone Health and Osteoporosis: A Report of the Surgeon General.
    1. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007 Mar;22(3):465–475. - PubMed
    1. Bass E, French DD, Bradham DD, et al. Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol. 2007 Jul;17(7):514–519. - PubMed
    1. Brenneman SK, Yurgin N, Fan Y. Cost and management of males with closed fractures. Osteoporos Int. 2013 Mar;24(3):825–833. - PubMed

MeSH terms